Practice
Featured experience
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
TWG Global / Mubadala $6.2 billion acquisition of Clear Channel Outdoor Holdings
We are advising TWG Global on the transaction
Qorvo $22 billion combination with Skyworks Solutions
We are advising Qorvo on the transaction
AkzoNobel $25 billion merger of equals with Axalta Coating Systems
We are advising AkzoNobel on the transaction
MicroStrategy $60.5 million tender offer
Davis Polk advised the dealer manager in connection with a “modified Dutch auction” cash tender offer by MicroStrategy…
Sterling Equities sale of the New York Mets
We advised Sterling Equities on the sale
Gilead Sciences $21 billion acquisition of Immunomedics
Davis Polk is advising Gilead Sciences, Inc. in its acquisition of Immunomedics, Inc. for $88.00 per share in cash. The…
Silver Lake investment in Reliance Industries’ Reliance Retail Ventures
Davis Polk is advising Reliance Industries Limited and Reliance Retail Ventures Limited in connection with Silver Lake’s…
Nestlé $2.6 billion acquisition of Aimmune Therapeutics
Davis Polk is advising JP Morgan Securities LLC and Lazard as financial advisers to Aimmune Therapeutics in connection with…
Emerson $1.6 billion acquisition of Open Systems International
Davis Polk is advising Emerson Electric Co. on its $1.6 billion acquisition of Open Systems International, Inc.
Emerson,…
San Juan Offshore acquisition of Arena Energy in prepackaged chapter 11 plan
Davis Polk is advising San Juan Offshore LLC (“San Juan”) on its proposed acquisition of Arena Energy LP (“Arena”) pursuant…
American Well strategic partnership with Google Cloud
Davis Polk is advising Amwell on its agreement to form a multi-year, strategic partnership with Google Cloud to deliver…
NN Inc. $825 million sale of life sciences unit to American Securities entities
Davis Polk is advising JP Morgan Securities LLC as financial adviser to NN, Inc. in connection with the $825 million sale of…
Bristol Myers Squibb acquisition of Forbius
Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and…